Accelerate Diagnostics, Inc. (AXDX)
USD 0.7
(-0.71%)
USD 0.7
(-0.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -54.02 Million USD | 13.98% |
| 2022 | -62.8 Million USD | 12.23% |
| 2021 | -71.56 Million USD | -12.34% |
| 2020 | -63.7 Million USD | 12.54% |
| 2019 | -72.83 Million USD | 9.38% |
| 2018 | -80.36 Million USD | -25.22% |
| 2017 | -64.18 Million USD | 3.49% |
| 2016 | -66.5 Million USD | -46.0% |
| 2015 | -45.54 Million USD | -44.52% |
| 2014 | -31.51 Million USD | -105.85% |
| 2013 | -15.31 Million USD | -186.08% |
| 2012 | -5.35 Million USD | -1207.2% |
| 2011 | -409.42 Thousand USD | -166.92% |
| 2010 | 611.79 Thousand USD | 190.09% |
| 2009 | -679.11 Thousand USD | 60.69% |
| 2008 | -1.72 Million USD | 18.3% |
| 2007 | -2.11 Million USD | 34.02% |
| 2006 | -3.2 Million USD | -41.86% |
| 2005 | -2.25 Million USD | -27.41% |
| 2004 | -1.77 Million USD | -14.63% |
| 2003 | -1.54 Million USD | -101.04% |
| 2002 | -769.29 Thousand USD | 46.53% |
| 2001 | -1.43 Million USD | 37.91% |
| 2000 | -2.31 Million USD | -339.76% |
| 1999 | -526.89 Thousand USD | -113.47% |
| 1998 | 3.91 Million USD | 388.9% |
| 1997 | 800 Thousand USD | -33.33% |
| 1996 | 1.2 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -10.15 Million USD | -20.9% |
| 2024 Q2 | -8.6 Million USD | 15.26% |
| 2023 FY | -54.02 Million USD | 13.98% |
| 2023 Q1 | -16.06 Million USD | -13.5% |
| 2023 Q3 | -14.65 Million USD | -16.41% |
| 2023 Q4 | -8.4 Million USD | 42.66% |
| 2023 Q2 | -12.58 Million USD | 21.65% |
| 2022 FY | -62.8 Million USD | 12.23% |
| 2022 Q4 | -14.15 Million USD | 4.19% |
| 2022 Q3 | -14.77 Million USD | 17.89% |
| 2022 Q1 | -15.89 Million USD | 18.12% |
| 2022 Q2 | -17.98 Million USD | -13.17% |
| 2021 Q1 | -20.02 Million USD | -32.79% |
| 2021 FY | -71.56 Million USD | -12.34% |
| 2021 Q2 | -17.59 Million USD | 12.17% |
| 2021 Q4 | -19.41 Million USD | -33.58% |
| 2021 Q3 | -14.53 Million USD | 17.38% |
| 2020 Q3 | -15.16 Million USD | 3.56% |
| 2020 Q4 | -15.08 Million USD | 0.55% |
| 2020 FY | -63.7 Million USD | 12.54% |
| 2020 Q1 | -17.73 Million USD | 2.96% |
| 2020 Q2 | -15.72 Million USD | 11.31% |
| 2019 Q2 | -18.08 Million USD | 3.91% |
| 2019 Q3 | -17.65 Million USD | 2.4% |
| 2019 Q1 | -18.82 Million USD | 4.74% |
| 2019 FY | -72.83 Million USD | 9.38% |
| 2019 Q4 | -18.27 Million USD | -3.5% |
| 2018 Q2 | -20.41 Million USD | 1.97% |
| 2018 FY | -80.36 Million USD | -25.22% |
| 2018 Q4 | -19.75 Million USD | -2.01% |
| 2018 Q3 | -19.36 Million USD | 5.12% |
| 2018 Q1 | -20.82 Million USD | -29.07% |
| 2017 Q1 | -14.31 Million USD | 10.7% |
| 2017 Q2 | -16.42 Million USD | -14.77% |
| 2017 Q3 | -17.31 Million USD | -5.43% |
| 2017 Q4 | -16.13 Million USD | 6.81% |
| 2017 FY | -64.18 Million USD | 3.49% |
| 2016 Q1 | -15.17 Million USD | -21.22% |
| 2016 Q4 | -16.02 Million USD | 7.99% |
| 2016 Q2 | -17.88 Million USD | -17.91% |
| 2016 Q3 | -17.41 Million USD | 2.64% |
| 2016 FY | -66.5 Million USD | -46.0% |
| 2015 Q3 | -11.2 Million USD | 8.65% |
| 2015 Q4 | -12.51 Million USD | -11.68% |
| 2015 FY | -45.54 Million USD | -44.52% |
| 2015 Q1 | -9.55 Million USD | -8.89% |
| 2015 Q2 | -12.26 Million USD | -28.35% |
| 2014 Q1 | -5.74 Million USD | -10.82% |
| 2014 Q4 | -8.77 Million USD | 0.56% |
| 2014 Q3 | -8.82 Million USD | -8.11% |
| 2014 FY | -31.51 Million USD | -105.85% |
| 2014 Q2 | -8.16 Million USD | -42.07% |
| 2013 Q2 | -3.77 Million USD | -48.1% |
| 2013 Q3 | -3.79 Million USD | -0.51% |
| 2013 FY | -15.31 Million USD | -186.08% |
| 2013 Q4 | -5.18 Million USD | -36.59% |
| 2013 Q1 | -2.55 Million USD | 37.22% |
| 2012 Q2 | -4.16 Million USD | -916.11% |
| 2012 Q3 | -1.67 Million USD | 59.77% |
| 2012 FY | -5.35 Million USD | -1207.2% |
| 2012 Q4 | -4.06 Million USD | -142.3% |
| 2012 Q1 | -410.21 Thousand USD | -19.38% |
| 2011 FY | -409.42 Thousand USD | -166.92% |
| 2011 Q4 | -343.63 Thousand USD | 20.07% |
| 2011 Q2 | -277.93 Thousand USD | -107.67% |
| 2011 Q1 | -133.83 Thousand USD | -180.98% |
| 2011 Q3 | -429.9 Thousand USD | -54.68% |
| 2010 Q2 | 1.81 Million USD | 570.32% |
| 2010 Q4 | -47.63 Thousand USD | -195.31% |
| 2010 Q3 | 49.97 Thousand USD | -97.24% |
| 2010 FY | 611.79 Thousand USD | 190.09% |
| 2010 Q1 | -385.49 Thousand USD | 1.75% |
| 2009 Q4 | -392.36 Thousand USD | 7.32% |
| 2009 FY | -679.11 Thousand USD | 60.69% |
| 2009 Q1 | -225.74 Thousand USD | -93.06% |
| 2009 Q2 | -158.46 Thousand USD | 29.8% |
| 2009 Q3 | -423.37 Thousand USD | -167.17% |
| 2008 Q3 | -177.98 Thousand USD | 61.47% |
| 2008 Q1 | -368.32 Thousand USD | -2.63% |
| 2008 FY | -1.72 Million USD | 18.3% |
| 2008 Q4 | -116.92 Thousand USD | 34.3% |
| 2008 Q2 | -461.91 Thousand USD | -25.41% |
| 2007 Q1 | -520.49 Thousand USD | -204.51% |
| 2007 Q3 | -538.49 Thousand USD | -12.5% |
| 2007 Q2 | -478.65 Thousand USD | 8.04% |
| 2007 FY | -2.11 Million USD | 34.02% |
| 2007 Q4 | -358.88 Thousand USD | 33.35% |
| 2006 Q4 | 498.04 Thousand USD | 180.68% |
| 2006 Q3 | -617.28 Thousand USD | 10.58% |
| 2006 Q2 | -690.29 Thousand USD | 18.23% |
| 2006 Q1 | -844.13 Thousand USD | 0.66% |
| 2006 FY | -3.2 Million USD | -41.86% |
| 2005 Q2 | 1.93 Million USD | 425.13% |
| 2005 Q3 | -819.34 Thousand USD | -142.39% |
| 2005 Q1 | -594.45 Thousand USD | -65.34% |
| 2005 FY | -2.25 Million USD | -27.41% |
| 2005 Q4 | -849.72 Thousand USD | -3.71% |
| 2004 Q2 | -577.83 Thousand USD | -76.13% |
| 2004 Q4 | -359.52 Thousand USD | 33.16% |
| 2004 Q1 | -328.07 Thousand USD | 20.85% |
| 2004 Q3 | -537.86 Thousand USD | 6.92% |
| 2004 FY | -1.77 Million USD | -14.63% |
| 2003 Q2 | -709.4 Thousand USD | -151.33% |
| 2003 FY | -1.54 Million USD | -101.04% |
| 2003 Q1 | -282.26 Thousand USD | 8.48% |
| 2003 Q3 | -452.48 Thousand USD | 36.22% |
| 2003 Q4 | -414.51 Thousand USD | 8.39% |
| 2002 Q1 | -139.16 Thousand USD | 35.28% |
| 2002 FY | -769.29 Thousand USD | 46.53% |
| 2002 Q4 | -308.43 Thousand USD | -25.13% |
| 2002 Q3 | -246.48 Thousand USD | -65.61% |
| 2002 Q2 | -148.84 Thousand USD | -6.95% |
| 2001 Q2 | -354.08 Thousand USD | -13.43% |
| 2001 Q3 | -266.25 Thousand USD | 24.81% |
| 2001 Q4 | -215.03 Thousand USD | 19.24% |
| 2001 FY | -1.43 Million USD | 37.91% |
| 2001 Q1 | -312.15 Thousand USD | 34.02% |
| 2000 Q3 | -299.44 Thousand USD | 59.26% |
| 2000 FY | -2.31 Million USD | -339.76% |
| 2000 Q2 | -734.96 Thousand USD | 18.12% |
| 2000 Q1 | -897.56 Thousand USD | -43.2% |
| 2000 Q4 | -473.07 Thousand USD | -57.98% |
| 1999 FY | -526.89 Thousand USD | -113.47% |
| 1999 Q4 | -626.8 Thousand USD | -52.38% |
| 1999 Q3 | -411.34 Thousand USD | -217.07% |
| 1999 Q2 | -129.73 Thousand USD | 48.55% |
| 1999 Q1 | -252.15 Thousand USD | -109.33% |
| 1998 Q1 | 1.68 Million USD | -9.23% |
| 1998 Q4 | -120.45 Thousand USD | -390.74% |
| 1998 Q3 | -24.54 Thousand USD | 96.48% |
| 1998 FY | 3.91 Million USD | 388.9% |
| 1998 Q2 | -697.9 Thousand USD | -141.3% |
| 1997 Q1 | 300 Thousand USD | 400.0% |
| 1997 Q2 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 1.05 Million USD | 252.7% |
| 1997 Q4 | 1.86 Million USD | 75.92% |
| 1997 FY | 800 Thousand USD | -33.33% |
| 1996 Q2 | 600 Thousand USD | 200.0% |
| 1996 Q3 | 300 Thousand USD | -50.0% |
| 1996 FY | 1.2 Million USD | 0.0% |
| 1996 Q4 | -100 Thousand USD | -133.33% |
| 1996 Q1 | 200 Thousand USD | 0.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -276.213% |
| Cerus Corporation | -30.05 Million USD | -79.776% |
| OrthoPediatrics Corp. | -25.76 Million USD | -109.687% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -408.674% |
| Talis Biomedical Corporation | -66.81 Million USD | 19.138% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -212.373% |
| Inogen, Inc. | -109.38 Million USD | 50.608% |
| Spectral AI, Inc. | -12.98 Million USD | -316.112% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 13.678% |
| CVRx, Inc. | -43.1 Million USD | -25.346% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1431.406% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -334.728% |
| Orthofix Medical Inc. | -139.11 Million USD | 61.162% |
| Venus Concept Inc. | -28.3 Million USD | -90.851% |
| Bioventus Inc. | -81.72 Million USD | 33.89% |
| BrainsWay Ltd. | -4.92 Million USD | -996.57% |
| Envoy Medical, Inc. | -18.37 Million USD | -194.094% |
| electroCore, Inc. | -18.8 Million USD | -187.307% |
| IceCure Medical Ltd | -15.57 Million USD | -246.867% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -11.439% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -212.879% |
| MaxCyte, Inc. | -48.29 Million USD | -11.862% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -351.919% |
| Nexalin Technology, Inc. | -5.69 Million USD | -848.476% |
| PAVmed Inc | -68.79 Million USD | 21.465% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 4.482% |
| RxSight, Inc. | -50.08 Million USD | -7.873% |
| Sight Sciences, Inc. | -57.27 Million USD | 5.667% |
| SI-BONE, Inc. | -46.93 Million USD | -15.122% |
| TELA Bio, Inc. | -44.07 Million USD | -22.582% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 0.225% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -5.056% |
| LivaNova PLC | -68.49 Million USD | 21.125% |
| 908 Devices Inc. | -42.75 Million USD | -26.358% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 68.841% |
| Nemaura Medical Inc. | -9.59 Million USD | -463.071% |
| NeuroPace, Inc. | -27.17 Million USD | -98.822% |
| LENSAR, Inc. | -12.22 Million USD | -341.802% |
| Apyx Medical Corporation | -17.25 Million USD | -213.042% |
| Cutera, Inc. | -156.23 Million USD | 65.418% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -527.94% |
| BioSig Technologies, Inc. | -28.51 Million USD | -89.492% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 38.352% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -140.702% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 148.444% |
| Axonics, Inc. | -26.05 Million USD | -107.345% |
| Outset Medical, Inc. | -169.77 Million USD | 68.176% |
| IRIDEX Corporation | -10 Million USD | -439.902% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 50.51% |
| IRadimed Corporation | 20.03 Million USD | 369.662% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -555.282% |
| INVO Bioscience, Inc. | -6.76 Million USD | -698.386% |
| Telesis Bio, Inc. | -35.15 Million USD | -53.707% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 477.027% |
| Varex Imaging Corporation | 32.1 Million USD | 268.312% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1478.617% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -345.298% |
| Pulmonx Corporation | -61.93 Million USD | 12.767% |
| Dynatronics Corporation | -2.27 Million USD | -2276.897% |
| Modular Medical, Inc. | -17.52 Million USD | -208.221% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -269.069% |
| Semler Scientific, Inc. | 22.25 Million USD | 342.757% |
| InMode Ltd. | 195.66 Million USD | 127.613% |
| Bruker Corporation | 436.9 Million USD | 112.366% |
| Cytosorbents Corporation | -31.2 Million USD | -73.115% |
| DexCom, Inc. | 597.7 Million USD | 109.039% |
| Align Technology, Inc. | 643.33 Million USD | 108.398% |
| Viveve Medical, Inc. | -21.55 Million USD | -150.675% |
| ZimVie Inc. | -30.93 Million USD | -74.627% |
| Movano Inc. | -29.69 Million USD | -81.974% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -94.031% |
| Nexalin Technology, Inc. | -5.69 Million USD | -848.476% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1431.406% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 76.835% |
| Profound Medical Corp. | -28.61 Million USD | -88.803% |
| Insulet Corporation | 220 Million USD | 124.558% |
| enVVeno Medical Corporation | -25.23 Million USD | -114.074% |
| Surmodics, Inc. | -5.64 Million USD | -857.095% |
| iCAD, Inc. | -7.68 Million USD | -602.666% |
| Nuwellis, Inc. | -17.63 Million USD | -206.455% |
| Biotricity, Inc. | -8.82 Million USD | -511.989% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 56.833% |
| Aethlon Medical, Inc. | -12.63 Million USD | -327.553% |
| InspireMD, Inc. | -21.14 Million USD | -155.536% |
| PAVmed Inc. | -68.79 Million USD | 21.465% |
| BIOLASE, Inc. | -17.93 Million USD | -201.21% |
| Beyond Air, Inc. | -63 Million USD | 14.249% |
| FONAR Corporation | 16.53 Million USD | 426.742% |
| AxoGen, Inc. | -21.46 Million USD | -151.738% |
| Vivani Medical, Inc. | -26.96 Million USD | -100.363% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 399.473% |
| Inari Medical, Inc. | -14.03 Million USD | -285.034% |
| UFP Technologies, Inc. | 57.66 Million USD | 193.695% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -996.436% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -756.803% |
| Tenon Medical, Inc. | -15.72 Million USD | -243.537% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -622.879% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -26.511% |
| AdaptHealth Corp. | -598.4 Million USD | 90.971% |
| Sintx Technologies, Inc. | -13.35 Million USD | -304.462% |
| NanoVibronix, Inc. | -3.43 Million USD | -1472.41% |
| Quanterix Corporation | -49.7 Million USD | -8.706% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -345.298% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -14043.455% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 83.847% |
| TransMedics Group, Inc. | -28.72 Million USD | -88.074% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -128.816% |
| NeuroMetrix, Inc. | -7.15 Million USD | -655.476% |
| Hyperfine, Inc. | -48.11 Million USD | -12.289% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 16.913% |
| Biomerica, Inc. | -6.36 Million USD | -748.563% |
| Bone Biologics Corporation | -9.42 Million USD | -473.041% |
| AVITA Medical, Inc. | -40.4 Million USD | -33.726% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -423.973% |
| Silk Road Medical, Inc | -59.27 Million USD | 8.846% |